Skip to content
Medical Health Aged Care, Women

MEDIA INVITATION: Is this the next big skin treatment trend? Meet StellarM22(TM) with XPL(TM) – The Next Generation of Skin Technology Launches in Australia.

Lumenis Aesthetics Australia & New Zealand 2 mins read
Key Facts:

📍 Crown Sydney
      1 Barangaroo Ave, Barangaroo

📅 March 16

12:00 PM – 5:00 PM


Skin rejuvenation is entering a new era and those covering the future of beauty are invited to see it first-hand.

Lumenis, the global pioneers behind Intense Pulsed Light (IPL) technology, are launching StellarM22™ with XPL™ (Expert Pulsed Light) - an advanced next-generation platform designed to treat over 30 skin conditions across all skin types.

Backed by new clinical data presented at the American Society for Dermatologic Surgery (ASDS) meeting, the technology demonstrated up to 70% improvement in pigmented and vascular lesions after a single treatment session.

To mark the Australian launch, Lumenis will host an exclusive event in Sydney on March 16 at Crown, Barangaroo, offering attendees a first look at the technology shaping the future of non-invasive skin treatments.

Attendees will have the opportunity to:

• Hear from leading aesthetic experts and practitioners

• Discover emerging trends shaping the global aesthetics industry

• Learn about the clinical science behind StellarM22™ with XPL™

• Experience a first-hand look at the technology behind some of today’s most in-demand skin treatments

Already installed in thousands of clinics worldwide, the M22 platform has become one of the most trusted technologies in aesthetic dermatology.

The new StellarM22™ with XPL™ introduces advanced Expert Pulsed Light technology, designed to deliver faster treatments, greater precision, and improved patient outcomes.

RSVP / Media Enquiries

To register or confirm attendance, please contact:

Kate Boissett
Head of Marketing – Lumenis Aesthetics
0422 734 622
[email protected]

 


Contact details:

Kate Boissett
Head of Marketing – Lumenis Aesthetics
0422 734 622
[email protected]

Media

More from this category

  • General News, Medical Health Aged Care
  • 11/03/2026
  • 07:45
Australian and New Zealand Journal of Public Health / Public Health Association of Australia

Public health experts call for rethink as dementia becomes leading cause of death

11 March 2026 - Leading public health experts have come together today to warn that deteriorating brain health is a rapidly growing public health threat in Australia, highlighting the need for preventive action. The call to action coincides with a letter published in the Australian and New Zealand Journal of Public Health referencing recent data from the Australian Institute of Health and Welfare and Australian Bureau of Statistics showing dementia has overtaken heart disease as the leading cause of death in Australia. Letter co-author, Professor Tanya Buchanan, CEO, Dementia Australia, says the latest statistics are a wake-up call. “Dementia is…

  • Medical Health Aged Care, Science
  • 11/03/2026
  • 07:00
UNSW Sydney

IVF not linked to higher overall cancer rates, but study shows differences in some cancers

A UNSW-led study found overall invasive cancer rates in Australian women were no higher after fertility treatments including IVF. Some specific cancers were slightly more common, while others were less common. Women who used fertility treatments had no higher overall risk of invasive cancer than other women, a large Australian study led by researchers from UNSW Sydney has found. The study, published today in JAMA Network Open, analysed health records of more than 417,000 women and found some specific cancers were slightly more common, while others were less common. The researchers say the findings need to be interpreted with caution,…

  • Medical Health Aged Care
  • 11/03/2026
  • 00:10
Egg Medical, Inc.

Egg Medical Presents CRT 2026 Data Demonstrating a Responsible Path to Light Lead and Lead-Apron Free Protection

WASHINGTON, March 10, 2026 (GLOBE NEWSWIRE) -- Egg Medical, a leader in enhanced radiation protection devices (ERPD), today announced the results of a Late-Breaking Trial presented at the Cardiovascular Research Technologies (CRT) 2026 conference. The study, presented by Santiago Garcia, MD, of The Christ Hospital, confirms that the addition of the EggNest™ system reduces levels of scatter radiation to all members of the interventional team to the extent that users could do procedures safely without the use of lead aprons or wear ultralight aprons.“For decades, the interventional community has accepted a trade-off: protect your long-term health from the effects of…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.